Software Healthcare Sector

Akanda

Market Cap: US$2.8m

Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.

Bone Biologics

Market Cap: US$2.7m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

Awakn Life Sciences

Market Cap: CA$4.0m

A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.

Optimus Healthcare Services

Market Cap: US$2.7m

Provides community-based oncology practices with the necessary infrastructure and support to enroll their patients on clinical trials in the United States.

Herbal Dispatch

Market Cap: CA$3.7m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Patrys

Market Cap: AU$4.1m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

Endexx

Market Cap: US$2.7m

Engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market.

Windtree Therapeutics

Market Cap: US$2.7m

A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.

Scinai Immunotherapeutics

Market Cap: US$2.6m

A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.

Tivic Health Systems

Market Cap: US$2.6m

Operates as a health tech company, develops and commercializes bioelectronic medicine.

Marvel Biosciences

Market Cap: CA$3.6m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Alzamend Neuro

Market Cap: US$2.6m

A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

Neural Therapeutics

Market Cap: CA$3.5m

A drug discovery company, focuses on plant-based active substances.

Psyence Biomedical

Market Cap: US$2.6m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Talis Biomedical

Market Cap: US$2.6m

Operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.

Can B

Market Cap: US$2.6m

Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.

Spruce Biosciences

Market Cap: US$2.6m

A biopharmaceutical company, focuses on developing and commercializing novel therapies for neurological disorders.

VirExit Technologies

Market Cap: US$2.5m

Develops and provides antiviral technologies, personal protective equipment, and health and wellness products.

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

Revelation Biosciences

Market Cap: US$2.5m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Ridder Titan Genesis

Market Cap: US$2.5m

A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.

Xebra Brands

Market Cap: CA$3.4m

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

Stem Cell Authority

Market Cap: US$2.4m

A technology development company, focuses on the collection and cryogenic preservation of stem cells.

One World Products

Market Cap: US$2.4m

One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients for medical and industrial uses.

THC Biomed Intl

Market Cap: CA$3.3m

Produces and sells medical and recreational cannabis in Canada.

Escalon Medical

Market Cap: US$2.4m

Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally.

Helius Medical Technologies

Market Cap: US$2.3m

A neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.

Strainsforpains

Market Cap: US$2.3m

Operates as a medical marijuana data recommendation system.

Venus Concept

Market Cap: US$2.3m

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

PHSC

Market Cap: UK£1.7m

Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.

AXIM Biotechnologies

Market Cap: US$2.3m

Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.

SETO Holdings

Market Cap: US$2.3m

A development stage company, provides healthcare services.

Cambium Bio

Market Cap: AU$3.5m

A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.

ReShape Lifesciences

Market Cap: US$2.2m

Provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.

Intelicare Holdings

Market Cap: AU$3.4m

Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

Theriva Biologics

Market Cap: US$2.2m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.